Form 4: Accuray Director Receives 354,609 Restricted Stock Award
Insider Transaction Report
Accuray Inc. Director Steven F. Mayer was granted 354,609 restricted shares of common stock under the company's equity incentive plan, vesting in one year.
Summary
- Director Steven F. Mayer of Accuray Inc. (ARAY) was awarded 354,609 restricted shares of common stock.
- The award was made under the Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan.
- The shares will vest 100% on the first anniversary of the grant date, which is October 31, 2025.
- The transaction date for the award is October 31, 2025.
Sentiment
Score: 7
Explanation: The grant of restricted stock to a director is generally a positive sign, indicating alignment of interests and a commitment to the company's long-term performance. It's a routine compensation event, not indicative of major operational changes.
Positives
- The grant of restricted stock to a director aligns their interests with long-term shareholder value.
- The award utilizes an existing equity incentive plan, indicating structured compensation practices.
Future Outlook
The 354,609 restricted shares granted to Director Steven F. Mayer are scheduled to vest 100% on October 31, 2026, which is the first anniversary of the grant date.
Industry Context
Equity awards to directors are a common practice across industries, particularly in technology and medical device sectors like Accuray, to incentivize long-term commitment and align leadership interests with shareholder returns.
Comparison to Industry Standards
- Granting restricted stock to directors is a standard practice in corporate governance, aligning director incentives with company performance.
- The vesting schedule of one year is typical for such awards, promoting retention and long-term focus.
- The size of the award would need to be compared to similar director compensation packages at peer companies within the medical device industry to assess its relative value, but such comparative data is not provided in this filing.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Award of restricted shares under the existing Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan. | 10/31/2025 | Reinforces director alignment with shareholder interests through equity ownership. |
Related Party Transactions
- The transaction involves an award of common stock to Steven F. Mayer, a director of Accuray Inc., making it a related party transaction.
Stakeholder Impact
- Shareholders: Potential positive impact as director's interests are further aligned with long-term share price performance.
- Employees: No direct impact mentioned, but part of a broader equity incentive plan.
Next Steps
- The 354,609 restricted shares will vest on October 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 10/31/2025 | Date of award of 354,609 restricted shares of common stock to Director Steven F. Mayer. |
| 11/03/2025 | Date the Form 4 was signed and filed. |
| 10/31/2026 | Expected vesting date for 100% of the 354,609 restricted shares (first anniversary of grant date). |
Recommendation
holdThis Form 4 filing reports a routine equity award to a director, which is a standard compensation practice. It does not provide new information that would fundamentally alter the investment thesis for Accuray Inc. Therefore, a 'hold' recommendation is appropriate, as this event alone is unlikely to drive significant price movement or warrant a change in investment strategy.
Keywords
Accuray Inc., ARAY, Steven F. Mayer, Restricted Stock, Equity Incentive Plan, Director Compensation, SEC Form 4, Stock Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.